Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Bodil Elisabeth Engelmann, Annika Loft, Andreas Kjær, Hans Jørgen Nielsen, Anne Kiil Berthelsen, Tina Binderup, Kim Brinch, Nils Brünner, Thomas Alexander Gerds, Gunilla Høyer-Hansen, Michael Holmsgaard Kristensen, Engin Yeter Kurt, Jan Erik Latocha, Gunnar Lindblom, Carsten Sloth & Liselotte Højgaard. (2014) Positron emission tomography/computed tomography for optimized colon cancer staging and follow up. Scandinavian Journal of Gastroenterology 49:2, pages 191-201.
Read now
Read now
Hans J. Nielsen, Karen V. Jakobsen, Ib J. Christensen & Nils Brünner. (2011) Screening for colorectal cancer: possible improvements by risk assessment evaluation?. Scandinavian Journal of Gastroenterology 46:11, pages 1283-1294.
Read now
Read now
Maria H. Lönnkvist, Elvar Theodorsson, Mikael Holst, Tryggve Ljung & Per M. Hellström. (2011) Blood chemistry markers for evaluation of inflammatory activity in Crohn's disease during infliximab therapy. Scandinavian Journal of Gastroenterology 46:4, pages 420-427.
Read now
Read now
Karin Mengele, Rudolf Napieralski, Viktor Magdolen, Ute Reuning, Apostolos Gkazepis, Fred Sweep, Nils Brünner, John Foekens, Nadia Harbeck & Manfred Schmitt. (2010) Characteristics of the level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1. Expert Review of Molecular Diagnostics 10:7, pages 947-962.
Read now
Read now
Articles from other publishers (37)
Athanasios Chalkias, Nikolaos Papagiannakis, Bernd Saugel, Moritz Flick, Konstantina Kolonia, Zacharoula Angelopoulou, Dimitrios Ragias, Dimitra Papaspyrou, Aikaterini Bouzia, Nicoletta Ntalarizou, Konstantinos Stamoulis, Aikaterini Kyriakaki, Jesper Eugen-Olsen, Eleni Laou & Eleni Arnaoutoglou. (2022) Association of Preoperative Basal Inflammatory State, Measured by Plasma suPAR Levels, with Intraoperative Sublingual Microvascular Perfusion in Patients Undergoing Major Non-Cardiac Surgery. Journal of Clinical Medicine 11:12, pages 3326.
Crossref
Crossref
Athanasios Chalkias, Eleni Laou, Konstantina Kolonia, Dimitrios Ragias, Zacharoula Angelopoulou, Eleni Mitsiouli, Thomas Kallemose, Lars Smith-Hansen, Jesper Eugen-Olsen & Eleni Arnaoutoglou. (2022) Elevated preoperative suPAR is a strong and independent risk marker for postoperative complications in patients undergoing major noncardiac surgery (SPARSE). Surgery 171:6, pages 1619-1625.
Crossref
Crossref
Katarzyna Śmiłowska, Marek Śmiłowski, Robert Partyka, Danuta Kokocińska & Przemysław Jałowiecki. (2022) Personalised Approach to Diagnosing and Managing Ischemic Stroke with a Plasma-Soluble Urokinase-Type Plasminogen Activator Receptor. Journal of Personalized Medicine 12:3, pages 457.
Crossref
Crossref
Kristian Blomberg, Torben F. Hansen, Claus L. Brasen, Jeppe B. Madsen, Lars H. Jensen & Caroline B. Thomsen. (2021) The Soluble Urokinase-Type Plasminogen Activator Receptor as a Biomarker for Survival and Early Treatment Effect in Metastatic Colorectal Cancer. Cancers 13:20, pages 5100.
Crossref
Crossref
Seong Beom Ahn, Karthik S. Kamath, Abidali Mohamedali, Zainab Noor, Jemma X. Wu, Dana Pascovici, Subash Adhikari, Harish R. Cheruku, Gilles J. Guillemin, Matthew J. McKay, Edouard C. Nice & Mark S. Baker. (2021) Use of a Recombinant Biomarker Protein DDA Library Increases DIA Coverage of Low Abundance Plasma Proteins. Journal of Proteome Research 20:5, pages 2374-2389.
Crossref
Crossref
Hans C. Rolff, Ib J. Christensen, Lars B. Svendsen, Michael Wilhelmsen, Ida K. Lund, Tine Thurison, Gunilla Høyer‐Hansen, Martin Illemann & Hans J. Nielsen. (2019) The concentration of the cleaved suPAR forms in pre‐ and postoperative plasma samples improves the prediction of survival in colorectal cancer: A nationwide multicenter validation and discovery study. Journal of Surgical Oncology 120:8, pages 1404-1411.
Crossref
Crossref
Akanksha Roberts, Prem Prakash Tripathi & Sonu Gandhi. (2019) Graphene nanosheets as an electric mediator for ultrafast sensing of urokinase plasminogen activator receptor-A biomarker of cancer. Biosensors and Bioelectronics 141, pages 111398.
Crossref
Crossref
N Hasan, M Mukim, P Sharma, U. S. Baghel & M. Khalid. (2019) CURRENT UPDATES ON DIAGNOSTIC BIOMARKERS OF HEPATOCELLULAR CARCINOMA. INDIAN DRUGS 56:06, pages 7-23.
Crossref
Crossref
Jeppe Meyer, Morten Alstrup, Line J. H. Rasmussen, Martin Schultz, Steen Ladelund, Thomas H. Haupt, Jens Tingleff, Kasper Iversen & Jesper Eugen-Olsen. (2018) suPAR is associated with risk of future acute surgery and post-operative mortality in acutely admitted medical patients. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 26:1.
Crossref
Crossref
Gitte Kristensen, Kasper Drimer Berg, Solvej Lippert, Ib Jarle Christensen, Klaus Brasso, Gunilla Høyer-Hansen & Martin Andreas Røder. (2017) Plasma levels of intact and cleaved urokinase plasminogen activator receptor (uPAR) in men with clinically localised prostate cancer. Journal of Clinical Pathology 70:12, pages 1063-1068.
Crossref
Crossref
Tomohiro Fujisaka, Shu-ichi Fujita, Daichi Maeda, Kensaku Shibata, Hideaki Takahashi, Hideaki Morita, Yoshihiro Takeda, Takahide Ito, Koichi Sohmiya, Masaaki Hoshiga & Nobukazu Ishizaka. (2017) Association between suPAR and cardiac diastolic dysfunction among patients with preserved ejection fraction. Heart and Vessels 32:11, pages 1327-1336.
Crossref
Crossref
Concetta Di Mauro, Ada Pesapane, Luigi Formisano, Roberta Rosa, Valentina D’Amato, Paola Ciciola, Alberto Servetto, Roberta Marciano, Roberta Clara Orsini, Francesca Monteleone, Nicola Zambrano, Gabriella Fontanini, Adele Servadio, Giuseppe Pignataro, Lucia Grumetto, Antonio Lavecchia, Dario Bruzzese, Antonino Iaccarino, Giancarlo Troncone, Bianca Maria Veneziani, Nunzia Montuori, Sabino De Placido & Roberto Bianco. (2017) Urokinase-type plasminogen activator receptor (uPAR) expression enhances invasion and metastasis in RAS mutated tumors. Scientific Reports 7:1.
Crossref
Crossref
Hong Guo, Lan-Xia Zhou, Haizhen Ma, Bei Liu, Juan Cheng, Yun-Yun Ma & Li Zhao. (2017) Soluble urokinase-type plasminogen activator receptor and urokinase-type plasminogen activator receptor contribute to chemoresistance in leukemia. Oncology Letters 14:1, pages 383-389.
Crossref
Crossref
Line Jee Hartmann Rasmussen, Martin Schultz, Anne Gaardsting, Steen Ladelund, Peter Garred, Kasper Iversen, Jesper Eugen-Olsen, Morten Helms, Kim Peter David, Andreas Kjaer, Anne-Mette Lebech & Gitte Kronborg. (2017) Inflammatory biomarkers and cancer: CRP and suPAR as markers of incident cancer in patients with serious nonspecific symptoms and signs of cancer. International Journal of Cancer 141:1, pages 191-199.
Crossref
Crossref
Tine Thurison, Kasper Almholt, Henrik Gårdsvoll, Michael Ploug, Gunilla Høyer-Hansen & Ida K. Lund. (2016) Urokinase receptor cleavage correlates with tumor volume in a transgenic mouse model of breast cancer. Molecular Carcinogenesis 55:5, pages 717-731.
Crossref
Crossref
Solvej Lippert, Kasper D Berg, Gunilla Høyer-Hansen, Ida K Lund, Peter Iversen, Ib J Christensen, Klaus Brasso & Martin A Røder. (2016) Copenhagen uPAR prostate cancer (CuPCa) database: protocol and early results. Biomarkers in Medicine 10:2, pages 209-216.
Crossref
Crossref
Line S. Tarpgaard, Ib J. Christensen, Gunilla Høyer-Hansen, Ida K. Lund, Tormod K. Guren, Bengt Glimelius, Halfdan Sorbye, Kjell M. Tveit, Hans Jørgen Nielsen, José M. A. Moreira, Per Pfeiffer & Nils Brünner. (2015) Intact and cleaved plasma soluble urokinase receptor in patients with metastatic colorectal cancer treated with oxaliplatin with or without cetuximab. International Journal of Cancer 137:10, pages 2470-2477.
Crossref
Crossref
Ganji Purnachandra Nagaraju, Tua-Elisabeth Long, Wungki Park, Jerome C. Landry, LaTonia Taliaferro-Smith, Alton B. Farris, Roberto Diaz & Bassel F. El-Rayes. (2015) Heat shock protein 90 promotes epithelial to mesenchymal transition, invasion, and migration in colorectal cancer. Molecular Carcinogenesis 54:10, pages 1147-1158.
Crossref
Crossref
Massimo Alfano, Paola Cinque, Guido Giusti, Silvia Proietti, Manuela Nebuloni, Silvio Danese, Silvia D’Alessio, Marco Genua, Federica Portale, Manuela Lo Porto, Pravin C. Singhal, Maria Pia Rastaldi, Moin A. Saleem, Domenico Mavilio & Joanna Mikulak. (2015) Full-length soluble urokinase plasminogen activator receptor down-modulates nephrin expression in podocytes. Scientific Reports 5:1.
Crossref
Crossref
Martin C. Boonstra, Pieter B.A.A. van Driel, Danny M. van Willigen, Marieke A. Stammes, Hendrica A.J.M. Prevoo, Quirijn R.J.G. Tummers, Andrew P. Mazar, Freek J. Beekman, Peter J.K. Kuppen, Cornelis J.H. van de Velde, Clemens W.G.M. Löwik, John V. Frangioni, Fijs W.B. van Leeuwen, Cornelis F.M. Sier & Alexander L. Vahrmeijer. (2015) uPAR-targeted multimodal tracer for pre- and intraoperative imaging in cancer surgery. Oncotarget 6:16, pages 14260-14273.
Crossref
Crossref
Andrew S. Gilder, Karra A. Jones, Jingjing Hu, Lei Wang, Clark C. Chen, Bob S. Carter & Steven L. Gonias. (2015) Soluble Urokinase Receptor Is Released Selectively by Glioblastoma Cells That Express Epidermal Growth Factor Receptor Variant III and Promotes Tumor Cell Migration and Invasion*. Journal of Biological Chemistry 290:24, pages 14798-14809.
Crossref
Crossref
Seong Beom Ahn, Charles Chan, Owen F. Dent, Abidali Mohamedali, Sun Young Kwun, Candice Clarke, Julie Fletcher, Pierre H. Chapuis, Edouard C. Nice & Mark S. Baker. (2015) Epithelial and Stromal Cell Urokinase Plasminogen Activator Receptor Expression Differentially Correlates with Survival in Rectal Cancer Stages B and C Patients. PLOS ONE 10:2, pages e0117786.
Crossref
Crossref
Athina Chounta, Christofer Ellinas, Vassiliki Tzanetakou, Fani Pliarhopoulou, Virginia Mplani, Angelos Oikonomou, Kostantinos Leventogiannis & Evangelos J. Giamarellos-Bourboulis. (2015) Serum soluble urokinase plasminogen activator receptor as a screening test for the early diagnosis of hepatocellular carcinoma. Liver International 35:2, pages 601-607.
Crossref
Crossref
Nobuhiro Tsuchiya. (2015) Biomarkers for the early diagnosis of hepatocellular carcinoma. World Journal of Gastroenterology 21:37, pages 10573.
Crossref
Crossref
Martin C Boonstra, Floris PR Verbeek, Andrew P Mazar, Hendrica AJM Prevoo, Peter JK Kuppen, Cornelis JH van de Velde, Alexander L Vahrmeijer & Cornelis FM Sier. (2014) Expression of uPAR in tumor-associated stromal cells is associated with colorectal cancer patient prognosis: a TMA study. BMC Cancer 14:1.
Crossref
Crossref
M. Grunnet, I.J. Christensen, U. Lassen, L.H. Jensen, M. Lydolph, I.K. Lund, T. Thurison, G. Høyer-Hansen & M. Mau-Sørensen. (2014) Prognostic significance of circulating intact and cleaved forms of urokinase plasminogen activator receptor in inoperable chemotherapy treated cholangiocarcinoma patients. Clinical Biochemistry 47:7-8, pages 599-604.
Crossref
Crossref
Morten Persson, Henrik H. El Ali, Tina Binderup, Andreas Pfeifer, Jacob Madsen, Palle Rasmussen & Andreas Kjaer. (2014) Dosimetry of 64Cu-DOTA-AE105, a PET tracer for uPAR imaging. Nuclear Medicine and Biology 41:3, pages 290-295.
Crossref
Crossref
Bodil E. EngelmannAnnika LoftAndreas KjærHans J. NielsenThomas A. GerdsEric v. BenzonNils BrünnerIb J. Christensen, Susanne H. Hansson, Niels H. Holländer, Michael H. KristensenJohan LöfgrenElena MarkovaCarsten SlothLiselotte Højgaard. (2014) Positron Emission Tomography/Computed Tomography and Biomarkers for Early Treatment Response Evaluation in Metastatic Colon Cancer. The Oncologist 19:2, pages 164-172.
Crossref
Crossref
Morten Persson & Andreas Kjaer. (2013)
Urokinase‐type plasminogen activator receptor (
uPAR
) as a promising new imaging target: potential clinical applications
. Clinical Physiology and Functional Imaging 33:5, pages 329-337.
Crossref
Crossref
Manuela Nebuloni, Lidia Zawada, Angelita Ferri, Antonella Tosoni, Pietro Zerbi, Massimo Resnati, Guido Poli, Luca Genovese & Massimo Alfano. (2013) HIV-1 Infected Lymphoid Organs Upregulate Expression and Release of the Cleaved Form of uPAR That Modulates Chemotaxis and Virus Expression. PLoS ONE 8:7, pages e70606.
Crossref
Crossref
Helge TaubertViktor Magdolen & Matthias Kotzsch. (2013) Impact of expression of the uPA system in sarcomas. Biomarkers in Medicine 7:3, pages 473-480.
Crossref
Crossref
NANCY ODDEN, TORE HENRIKSEN & LARS MØRKRID. (2012) Serum soluble urokinase plasminogen activator receptor (suPAR) in early pregnancy prior to clinical onset of preeclampsia. Acta Obstetricia et Gynecologica Scandinavica 91:10, pages 1226-1232.
Crossref
Crossref
Morten Persson, Palle Rasmussen, Jacob Madsen, Michael Ploug & Andreas Kjaer. (2012) New peptide receptor radionuclide therapy of invasive cancer cells: in vivo studies using 177Lu-DOTA-AE105 targeting uPAR in human colorectal cancer xenografts. Nuclear Medicine and Biology 39:7, pages 962-969.
Crossref
Crossref
Ole Didrik Laerum, Kjell Ovrebo, Arne Skarstein, Ib Jarle Christensen, Warner Alpízar-Alpízar, Lars Helgeland, Keld Danø, Boye Schnack Nielsen & Martin Illemann. (2012) Prognosis in adenocarcinomas of lower oesophagus, gastro-oesophageal junction and cardia evaluated by uPAR-immunohistochemistry. International Journal of Cancer 131:3, pages 558-569.
Crossref
Crossref
Tine Thurison, Ida K. Lund, Martin Illemann, Ib J. Christensen & Gunilla Høyer‐Hansen. 2012. Matrix Proteases in Health and Disease. Matrix Proteases in Health and Disease
325
344
.
G. Tzanakaki, M. Paparoupa, M. Kyprianou, A. Barbouni, J. Eugen-Olsen & J. Kourea-Kremastinou. (2011) Elevated soluble urokinase receptor values in CSF, age and bacterial meningitis infection are independent and additive risk factors of fatal outcome. European Journal of Clinical Microbiology & Infectious Diseases 31:6, pages 1157-1162.
Crossref
Crossref
T. Mölkänen, E. Ruotsalainen, C. W. Thorball & A. Järvinen. (2011) Elevated soluble urokinase plasminogen activator receptor (suPAR) predicts mortality in Staphylococcus aureus bacteremia. European Journal of Clinical Microbiology & Infectious Diseases 30:11, pages 1417-1424.
Crossref
Crossref